Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 1105 Print this page  Email this page Small font size Default font size Increase font size
This article has been cited by
1
Michael Rassner,Harald Lahner,Nikolas von Bubnoff,Frank Lammert
.2017;()1
[DOI]
268Ga-DOTANOC PET/CT in Multiple Endocrine Neoplasia 1 With Associated Adrenocortical Carcinoma
Shyma Basheer,Ramkesh Ratheesan,Manjit Sarma,Shanmuga Sundaram Palaniswamy,Anitha Mathews
Clinical Nuclear Medicine.2022;47(5)e389
[DOI]
3Long-term outcome of indigenous 177Lu-DOTATATE PRRT in patients with Metastatic Advanced Neuroendocrine Tumours: a single institutional observation in a large tertiary care setting
Keerti Sitani,Rahul V Parghane,Sanjay Talole,Sandip Basu
The British Journal of Radiology.2021;94(1117)20201041
[DOI]
4Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach?
Rossana Berardi,Mariangela Torniai,Agnese Savini,Silvia Rinaldi,Stefano Cascinu
World Journal of Clinical Oncology.2016;7(2)131
[DOI]
5What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?
Jooae Choe,Kyung Won Kim,Hyoung Jung Kim,Dong Wook Kim,Kyu Pyo Kim,Seung-Mo Hong,Jin-Sook Ryu,Sree Harsha Tirumani,Katherine Krajewski,Nikhil Ramaiya
Korean Journal of Radiology.2019;20(1)5
[DOI]
6Intrapancreatic accessory spleen mimicking malignant tumor: three case reports
Maria Zurek Munk-Madsen,Kristine Zakarian,Peter Sandor Oturai,Carsten Palnæs Hansen,Birgitte Federspiel,Eva Fallentin,Gro Linno Willemoe
Acta Radiologica Open.2019;8(6)205846011985934
[DOI]
7Peptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms): Fundamentals and Salient Clinical Practice Points for Medical Oncologists
Sandip Basu,Rahul Parghane,Rohit Ranade,Pradeep Thapa,Anant Ramaswamy,Vikas Ostwal,Bhawna Sirohi,Dipanjan Panda,Shailesh V Shrikhande
Indian Journal of Medical and Paediatric Oncology.2019;40(02)165
[DOI]
8Peptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms): Fundamentals and Salient Clinical Practice Points for Medical Oncologists
Doina Piciu
Indian Journal of Medical and Paediatric Oncology.2017;40(02)237
[DOI]
9PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy
Punit Sharma,Rakesh Kumar,Abass Alavi
PET Clinics.2015;10(4)495
[DOI]
10Biological Effects Induced by 68Ga-Conjugated Peptides in Human and Rodent Tumor Cell Lines
Marieta Elena Panait,Livia Chilug,Valentina Negoita,Antonela Busca,Gina Manda,Dana Niculae,Mirela Dumitru,Maria Iuliana Gruia
International Journal of Peptide Research and Therapeutics.2019;25(3)979
[DOI]
1168Ga-DOTATATE PET/MR Imaging of Urinary Bladder Paraganglioma
Rakesh S. Sajjan,Maria Gavra,Kanhaiyalal Agrawal,Rizwan Syed,Jamshed Bomanji
Clinical Nuclear Medicine.2015;40(8)692
[DOI]
12Approches de la médecine nucléaire au Liban dans les tumeurs neuroendocrines
F. Chehade,M. Ghosn,N. Hammoud,G. Mouharram,F. Farhat,J. Daher,M. Jreige,M. Haidar
Médecine Nucléaire.2015;39(8)e3
[DOI]
133P’s of Wermer/MEN1 Syndrome on 68Ga-DOTANOC PET/CT Scan
Sarthak Tripathy,Sneha Prakash,Sreedharan Thankarajan Arun Raj,Arunav Kumar,Shamim Ahmed Shamim
Clinical Nuclear Medicine.2020;45(12)e516
[DOI]
14Continued rapid growth in68Ga applications: update 2013 to June 2014
Irina Velikyan
Journal of Labelled Compounds and Radiopharmaceuticals.2015;58(3)99
[DOI]
15Aggressive variants of prostate cancer – Are we ready to apply specific treatment right now?
Igor Tsaur,Isabel Heidegger,Alexander Kretschmer,Hendrik Borgmann,Giorgio Gandaglia,Alberto Briganti,Pieter de Visschere,Romain Mathieu,Massimo Valerio,Roderick van den Bergh,Piet Ost,Cristian Mirvald,Derya Tilki,Guillaume Ploussard,Cristian Surcel
Cancer Treatment Reviews.2019;75(3)20
[DOI]
16Aggressive variants of prostate cancer – Are we ready to apply specific treatment right now?
Mohsen Beheshti,Alireza Rezaee,Markus Raderer,Werner Langsteger
Cancer Treatment Reviews.2018;75(3)85
[DOI]
17Cushing Syndrome Secondary to Primary Neuroendocrine Lung Carcinoma
A. Zainal,O. Akinsola,K. Rajamani
Case Reports in Endocrinology.2019;2019(3)1
[DOI]
18Accuracy of 68Ga DOTANOC PET/CT Imaging in Patients With Multiple Endocrine Neoplasia Syndromes
Punit Sharma,Anirban Mukherjee,Sellam Karunanithi,Niraj Naswa,Rakesh Kumar,Ariachery C. Ammini,Chandrasekhar Bal
Clinical Nuclear Medicine.2015;40(7)e351
[DOI]
19Qualitative Analysis of Long-Lived Residual Radioisotopes in 18 MeV Proton Bombarded Enriched Water Target
I Kambali,H Suryanto,H Rajiman,H Parwanto,F Rindiyantono,A A Billah,A A Pasha
Journal of Physics: Conference Series.2020;1436(1)012021
[DOI]
20Comparison of gallium-68 production yields from (p,2n), (a,2n) and (p,n) nuclear reactions applicable for cancer diagnosis
I Kambali,F A Wibowo
Journal of Physics: Conference Series.2019;1198(2)022003
[DOI]
21Comparison of gallium-68 production yields from (p,2n), (a,2n) and (p,n) nuclear reactions applicable for cancer diagnosis
Chih-Hao K. Kao
Journal of Physics: Conference Series.2017;1198(2)43
[DOI]
22PET imaging with 68gallium labelled somatostatin analogues in the evaluation of neuroendocrine tumours (NETs)
C. Ansquer,D. Taieb,F. Montravers,F. Tenenbaum
Médecine Nucléaire.2015;39(1)18
[DOI]
23Progress in the treatment of esophageal neuroendocrine carcinoma
Zheng Ma,Hongfei Cai,Youbin Cui
Tumor Biology.2017;39(6)101042831771131
[DOI]
24SPECT/CT in neuroendocrine tumours
Orazio Schillaci,Angela Spanu,Barbara Palumbo,Roberta Danieli
Clinical and Translational Imaging.2014;2(6)477
[DOI]
25Somatostatin Receptor Positron Emission Tomography: Beyond Gastroenteropancreatic Neuroendocrine Tumors
Gagandeep Choudhary,Samuel Galgano
Current Radiology Reports.2019;7(5)477
[DOI]
26Somatostatin Receptor Positron Emission Tomography: Beyond Gastroenteropancreatic Neuroendocrine Tumors
Michael Rassner,Harald Lahner,Nikolas von Bubnoff,Frank Lammert
Current Radiology Reports.2018;7(5)381
[DOI]
27Cushing Syndrome due to Ectopic Adrenocorticotropic Hormone Secretion by a Pulmonary Carcinoid Tumor in a Patient with Pneumoconiosis
Hazim Bukamur,Chelsey White,Rodhan Khthir,Alysia Browne,Fauzi Najar,Mohammed Al-Ourani
AACE Clinical Case Reports.2018;4(6)e521
[DOI]
28Comparison of Diagnostic Sensitivity and Quantitative Indices Between 68Ga-DOTATOC PET/CT and 111In-Pentetreotide SPECT/CT in Neuroendocrine Tumors: a Preliminary Report
Inki Lee,Jin Chul Paeng,Soo Jin Lee,Chan Soo Shin,Jin-Young Jang,Gi Jeong Cheon,Dong Soo Lee,June-Key Chung,Keon Wook Kang
Nuclear Medicine and Molecular Imaging.2015;49(4)284
[DOI]
29Imitators of chronic pancreatitis: diffuse neuroendocrine tumour of the pancreas
Haresh Naringrekar,Ashley Vogel,Anthony Prestipino,Haroon Shahid
BJR|case reports.2017;3(4)20170015
[DOI]
30Exceptional Visualization of the Gallbladder on 68Ga-DOTANOC PET/CT Imaging
Ritanshu Solanki,Harmandeep Singh,Rajender Kumar
Clinical Nuclear Medicine.2022;47(6)e468
[DOI]
31Nonfunctioning Incidental Pancreatic Neuroendocrine Tumors
Marina Gorelik,Mahmoud Ahmad,David Grossman,Martin Grossman,Avram M. Cooperman
Surgical Clinics of North America.2018;98(1)157
[DOI]
32Molecular imaging and therapy of somatostatin receptor positive tumors
Jana Ivanidze,Michelle Roytman,Arielle Sasson,Myrto Skafida,Thomas J. Fahey,Joseph R. Osborne,Silvina P. Dutruel
Clinical Imaging.2019;56(1)146
[DOI]
33Evaluation of a Correction Method for 111In-Pentetreotide SPECT Imaging of Gastroenteropancreatic Neuroendocrine Tumors
Takao Kanzaki,Yasuyuki Takahashi,Tetsuya Higuchi,Xieyi Zhang,Nao Mogi,Takayuki Suto,Yoshito Tsushima
Journal of Nuclear Medicine Technology.2020;48(4)326
[DOI]
34A Review of Streptococcus pyogenes: Public Health Risk Factors, Prevention and Control
Nelly Janira Avire,Harriet Whiley,Kirstin Ross
Pathogens.2021;10(2)248
[DOI]
  Feedback 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal